1. Home
  2. POWI vs AGIO Comparison

POWI vs AGIO Comparison

Compare POWI & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POWI
  • AGIO
  • Stock Information
  • Founded
  • POWI 1988
  • AGIO 2007
  • Country
  • POWI United States
  • AGIO United States
  • Employees
  • POWI N/A
  • AGIO N/A
  • Industry
  • POWI Semiconductors
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • POWI Technology
  • AGIO Health Care
  • Exchange
  • POWI Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • POWI 2.3B
  • AGIO 2.4B
  • IPO Year
  • POWI 1997
  • AGIO 2013
  • Fundamental
  • Price
  • POWI $37.67
  • AGIO $40.72
  • Analyst Decision
  • POWI Strong Buy
  • AGIO Strong Buy
  • Analyst Count
  • POWI 3
  • AGIO 5
  • Target Price
  • POWI $61.67
  • AGIO $57.25
  • AVG Volume (30 Days)
  • POWI 698.6K
  • AGIO 577.5K
  • Earning Date
  • POWI 11-05-2025
  • AGIO 10-30-2025
  • Dividend Yield
  • POWI 2.23%
  • AGIO N/A
  • EPS Growth
  • POWI N/A
  • AGIO N/A
  • EPS
  • POWI 0.59
  • AGIO 11.13
  • Revenue
  • POWI $442,468,000.00
  • AGIO $40,875,000.00
  • Revenue This Year
  • POWI $11.06
  • AGIO $23.76
  • Revenue Next Year
  • POWI $14.36
  • AGIO $148.23
  • P/E Ratio
  • POWI $63.85
  • AGIO $3.67
  • Revenue Growth
  • POWI 7.16
  • AGIO 30.57
  • 52 Week Low
  • POWI $37.62
  • AGIO $23.42
  • 52 Week High
  • POWI $69.53
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • POWI 29.03
  • AGIO 63.66
  • Support Level
  • POWI $38.59
  • AGIO $39.32
  • Resistance Level
  • POWI $39.78
  • AGIO $41.42
  • Average True Range (ATR)
  • POWI 1.34
  • AGIO 1.34
  • MACD
  • POWI -0.17
  • AGIO 0.34
  • Stochastic Oscillator
  • POWI 0.65
  • AGIO 87.58

About POWI Power Integrations Inc.

Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: